Colossal Biosciences
AUSTIN, TX · Founded 2021 · CIK 0001964433 · Biotech · Private
Gene-edited woolly mammoth through advanced genetics and synthetic biology
colossal.com →- Grants
- —
- No SBIR or STTR on record
- Sector median 1 award
- Raised
- $150M
- 1 Form D · Feb 2023
- 44 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 0 granted · 40 pending
- 20× sector median 2 patents
Capital Timeline
Federal ↑Equity ↓20222023
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $150,000,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 3379 | Polyrizon Ltd. | — | $7.5M |
| 3380 | BlossomHill Therapeutics | — | $246M |
| 3381 | Shattuck Labs, Inc. | — | $164M |
| 3382 | Colossal Biosciences | — | $150M |
| 3383 | PepGen Inc. | — | $127M |
| 3384 | MouSensor, Inc. | — | — |
| 3385 | AGEX THERAPEUTICS INC | — | $19M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Brian BeardDirector · Executive Officer
- Tom ChiDirector
- Benjamin LammDirector · Executive Officer
Patents
- Transgenic Animals And Recombinant Host Cells Comprising Specific Gene Variants And Methods Of Creating Sameapplication
- Three-dimensional Co-culture System For Embryos Cultured In Vitro And Uses Thereofapplication
- Nicotinamide Adenine Dinucleotide (nad+) Precursors, Nad Pathway Substrates Compositions And Uses Thereofapplication
- Manipulation Of Zona Pellucida To Facilitate Delivery Of Nucleic Acids For Gene Editing In Embryoapplication
- Methods And Compositions For Preventing Or Treating Cancerapplication
- Multi-Genome Editor Construct and Uses Thereofapplication
- Methods And Compositions For Creating Elephant Induced Pluripotent Stem Cellsapplication
- Methods And Compositions For Preventing Or Treating Cancerapplication
- An Apparatus And Method For A Microfluidic Culture Of Non-adherent Pre-implantation Cells, Tissues, Organoids, Or Embryos Under Environmentally Controlled, Highly Customizable Microenvironmentsapplication
- An Apparatus And Method For Housing And Transporting An Animalapplication
- Methods Of Generating Rock Hyrax Ipscapplication
- Methods And Compositions For Creating Elephant Induced Pluripotent Stem Cellsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.